(Q40712542)

23 September 2017

Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression (English)

1 reference

23 September 2017

Bschor T

1

1 reference

23 September 2017

Canata B

series ordinal

2

1 reference

23 September 2017

Müller-Oerlinghausen B

series ordinal

3

1 reference

23 September 2017

Bauer M

series ordinal

4

1 reference

23 September 2017

1 May 2001

1 reference

Journal of Affective Disorders

23 September 2017

1 reference

23 September 2017

64

1 reference

23 September 2017

261-265

1 reference

23 September 2017

2-3

1 reference

Predicting outcome of lithium added to antidepressants in resistant depression

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Current trends of research on antidepressive treatment and prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Refractory depression: a review with particular reference to the use of lithium augmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Improving depression severity assessment—II. Content, concurrent and external validity of three observer depression scales

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Improving depression severity assessment--I. Reliability, internal validity and sensitivity to change of three observer depression scales

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Simulation study of confounder-selection strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

High plasma nortriptyline levels in the treatment of depression. I

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Variability of response to lithium augmentation in refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

Adding lithium to antidepressant therapy: factors related to therapeutic potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

On the validity of the Bech-Rafaelsen Melancholia Scale (BRMS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900211-1

7 January 2021

10.1016/S0165-0327(00)00211-1

Identifiers

DOI

1 reference

23 September 2017

1 reference